« Back
Home /
Bevirimat

Bevirimat

Item no.	M1865-10mg
Manufacturer	AbMole
CASRN	174022-42-5
Amount	10mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Pancreatic Cancer
Type	Inhibitors
Specific against	other
Purity	>99%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BVM, MPC-4326, PA-457
Similar products	Bevirimat, BVM, MPC-4326, PA-457
Available
Target Information	HIV Protease
Molecular Weight	584, 82
Solubility	DMSO 10 mM
Bioactivity information	Bevirimat (BVM), also known as PA-457 or MPC-4326, is a novel Human Immunodeficiency Virus type 1 (HIV-1) maturation inhibitor.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1865-10mg-safety-datasheet.pdf